Evidence map›Paper›PMID 41387413›Full record

Trial reportNature communications2025

Gut Prevotella stercorea associates with protection against infection in rural African children.

Ogochukwu Ofordile, Dora I A Pereira, Andrew M Prentice, Josef Wagner

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02941081 (A Novel Nano-iron Supplement), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02941081 phase2completednot on this map

A Novel Nano-iron Supplement (IHAT) to Safely Combat Iron Deficiency and Anaemia (IDA) in Young Children: a Doubleblind Randomised Controlled Trial

TypeinterventionalSponsorLondon School of Hygiene and Tropical MedicineRan2018 to 2019Enrolled645ConditionsIron Deficiency, Anaemia in ChildrenArmsIHAT, Ferrous Sulphate, Placebo
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Bridging the gap:Gut microbes · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ogochukwu OfordileMedical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia. ofordile@gmail.com.ORCID http://orcid.org/0009-0000-6887-3092
Dora I A PereiraSanthera Pharmaceuticals, Pratteln, Switzerland.
Andrew M PrenticeMedical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.ORCID http://orcid.org/0000-0001-5389-451X
Josef WagnerWellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding how the gut microbiome confers immune protection in early life remains a fundamental challenge, particularly in high-infection-burden, underrepresented populations. Here, we analyse longitudinal stool microbiome and illness data from 633 Gambian children aged 7-37 months enroled in a randomised, double-blind iron supplementation trial (NCT02941081). The primary endpoint was correction of iron deficiency anaemia, and the secondary endpoint was diarrhoea incidence and other adverse events; IHAT was non-inferior to ferrous sulphate for iron correction and showed fewer moderate-to-severe diarrhoea episodes. Using 16S rRNA sequencing at three timepoints (Days 1, 15, and 85), we find that children who remained infection-free harboured a consistently higher relative abundance of Prevotella stercorea, a keystone taxon of non-industrialised gut ecologies. In contrast, Escherichia coli and other opportunistic pathogens were enriched in children who developed infections. These taxonomic signatures were temporally stable and embedded within distinct, co-occurring microbial networks. Strikingly, higher P. stercorea abundance was inversely associated with both infection frequency and duration, with the greatest differences observed in children aged 1-2 years, potentially explaining their increased infectious risk. Our findings reveal a Prevotella-dominated enterotype associated with reduced infection risk, with implications for vaccine responsiveness, child survival, and microbiota-targeted interventions in global child health.

Indexed as

Gastrointestinal MicrobiomePrevotellaAnemia, Iron-DeficiencyChild, PreschoolDiarrheaDouble-Blind MethodEscherichia coliFecesFemaleFerrous CompoundsGambiaHumansInfantIronMaleRNA, Ribosomal, 16SFerrous Compoundsferrous sulfateIronRNA, Ribosomal, 16S

Identifiers

PMID41387413
PMCPMC12701053

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.